Skip to main content

and
  1. Article

    Open Access

    Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database

    Guideline recommendations for the application of neoadjuvant chemotherapy (NACT) in T2N1M0 stage hormone receptor-positive, HER2-negative (HR + /HER2-) breast cancer are ambiguous. The debate continues regardi...

    Yuhang Shang, Xuelian Wang, Yansong Liu, Weilun Cheng, Yunqiang Duan in Breast Cancer (2024)

  2. Article

    Open Access

    Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer

    Estrogen receptor (ER) positive human epidermal growth factor receptor 2 (HER2) negative breast cancer (ER+/HER2−BC) and triple-negative breast cancer (TNBC) are two distinct breast cancer molecular subtypes, ...

    Yansong Liu, Mingcui Li, Zhengbo Fang, Shan Gao in Cancer Immunology, Immunotherapy (2024)